SandboxAB: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:25em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:25em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B| Acute Bacterial Uncomplicated | ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B| Acute Bacterial Uncomplicated Cystitis†}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Nitrofurantoin]] 100 mg po q12h×5 days'''''<br>OR<br>▸ '''''[[TMP-SMX]] 1 DS tab po q12h×3 days'''''<br>OR<br>'''''▸[[Fosfomycin]] 3 gm single dose'''''<br>OR<br> ▸'''''[[Pivmecillinam ]] 400 mg bid×5 days ''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Nitrofurantoin]] 100 mg po q12h×5 days'''''<br>OR<br>▸ '''''[[TMP-SMX]]‡ 1 DS tab po q12h×3 days'''''<br>OR<br>'''''▸[[Fosfomycin]] 3 gm single dose'''''<br>OR<br> ▸'''''[[Pivmecillinam]]♦ 400 mg bid×5 days ''''' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Alternative Regimen'' | ||
Line 15: | Line 15: | ||
|} | |} | ||
† Acute uncomplicated cystitis: Premenopausal, nonpregnant women with no known urological abnormalities or comorbidities,postmenopausal women or well-controlled diabetes female patient. | |||
‡Avoid if resistance prevalence is known to exceed 20% or if used for UTI in previous 3 months. | |||
♦Pivmecillinam is available in some European countries, not licensed in US. | |||
<br> | <br> |
Revision as of 05:25, 17 January 2014
† Acute uncomplicated cystitis: Premenopausal, nonpregnant women with no known urological abnormalities or comorbidities,postmenopausal women or well-controlled diabetes female patient. ‡Avoid if resistance prevalence is known to exceed 20% or if used for UTI in previous 3 months. ♦Pivmecillinam is available in some European countries, not licensed in US.
|